These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel, helper-dependent, adenovirus-retrovirus hybrid vector: stable transduction by a two-stage mechanism. Soifer H; Higo C; Logg CR; Jih LJ; Shichinohe T; Harboe-Schmidt E; Mitani K; Kasahara N Mol Ther; 2002 May; 5(5 Pt 1):599-608. PubMed ID: 11991751 [TBL] [Abstract][Full Text] [Related]
3. Forced integration of Moloney murine leukemia virus DNA with a mutant integration site occurs through recombination with VL30 DNA. Murphy JE; Goff SP Virology; 1994 Oct; 204(1):458-61. PubMed ID: 8091679 [TBL] [Abstract][Full Text] [Related]
4. Isolation and analysis of retroviral integration targets by solo long terminal repeat inverse PCR. Jin YF; Ishibashi T; Nomoto A; Masuda M J Virol; 2002 Jun; 76(11):5540-7. PubMed ID: 11991982 [TBL] [Abstract][Full Text] [Related]
5. Targeted transgene insertion into the CHO cell genome using Cre recombinase-incorporating integrase-defective retroviral vectors. Kawabe Y; Shimomura T; Huang S; Imanishi S; Ito A; Kamihira M Biotechnol Bioeng; 2016 Jul; 113(7):1600-10. PubMed ID: 26724679 [TBL] [Abstract][Full Text] [Related]
6. A novel self-deleting retroviral vector carrying an additional sequence recognized by the viral integrase (IN). Torne-Celer C; Moreau K; Faure C; Chebloune Y; Verdier G; Ronfort C Virus Res; 2008 Jul; 135(1):72-82. PubMed ID: 18420298 [TBL] [Abstract][Full Text] [Related]
7. Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site. Choulika A; Guyot V; Nicolas JF J Virol; 1996 Mar; 70(3):1792-8. PubMed ID: 8627702 [TBL] [Abstract][Full Text] [Related]
8. Inclusion of Moloney murine leukemia virus elements upstream of the transgene cassette in an E1-deleted adenovirus leads to an unusual genomic integration in epithelial cells. Zheng C; O'Connell BC; Baum BJ Virology; 2003 Sep; 313(2):460-72. PubMed ID: 12954213 [TBL] [Abstract][Full Text] [Related]
9. Genomic integration and gene expression by a modified adenoviral vector. Zheng C; Baum BJ; Iadarola MJ; O'Connell BC Nat Biotechnol; 2000 Feb; 18(2):176-80. PubMed ID: 10657124 [TBL] [Abstract][Full Text] [Related]
10. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system. Tashiro F; Niwa H; Miyazaki J Hum Gene Ther; 1999 Jul; 10(11):1845-52. PubMed ID: 10446924 [TBL] [Abstract][Full Text] [Related]
11. Cre/loxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transcription in human hematopoietic cells. Fernex C; Dubreuil P; Mannoni P; Bagnis C J Virol; 1997 Oct; 71(10):7533-40. PubMed ID: 9311833 [TBL] [Abstract][Full Text] [Related]
12. Development of high-titer retroviral producer cell lines by using Cre-mediated recombination. Vanin EF; Cerruti L; Tran N; Grosveld G; Cunningham JM; Jane SM J Virol; 1997 Oct; 71(10):7820-6. PubMed ID: 9311869 [TBL] [Abstract][Full Text] [Related]
13. Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene. Loew R; Selevsek N; Fehse B; von Laer D; Baum C; Fauser A; Kuehlcke K Mol Ther; 2004 May; 9(5):738-46. PubMed ID: 15120335 [TBL] [Abstract][Full Text] [Related]
14. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration. Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970 [TBL] [Abstract][Full Text] [Related]
15. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy. Junker U; Böhnlein E; Veres G Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553 [TBL] [Abstract][Full Text] [Related]
16. Stable transduction of actively dividing cells via a novel adenoviral/episomal vector. Leblois H; Roche C; Di Falco N; Orsini C; Yeh P; Perricaudet M Mol Ther; 2000 Apr; 1(4):314-22. PubMed ID: 10933949 [TBL] [Abstract][Full Text] [Related]
17. Self-deleting retrovirus vectors for gene therapy. Russ AP; Friedel C; Grez M; von Melchner H J Virol; 1996 Aug; 70(8):4927-32. PubMed ID: 8763996 [TBL] [Abstract][Full Text] [Related]
18. Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses. Torrent C; Jullien C; Klatzmann D; Perricaudet M; Yeh P Cancer Gene Ther; 2000 Aug; 7(8):1135-44. PubMed ID: 10975674 [TBL] [Abstract][Full Text] [Related]
19. Transient gene expression mediated by integrase-defective retroviral vectors. Yu SS; Dan K; Chono H; Chatani E; Mineno J; Kato I Biochem Biophys Res Commun; 2008 Apr; 368(4):942-7. PubMed ID: 18279658 [TBL] [Abstract][Full Text] [Related]
20. Human foamy virus integrase fails to catalyse the integration of a circular DNA molecule containing an LTR junction sequence. Russell RA; Critchley R; Vassaux G; McClure MO Gene Ther; 2002 Oct; 9(19):1326-32. PubMed ID: 12224016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]